Furthermore, the immune pathways including Response to Wounding, Immunological Synapse, and BioCarta IL17 Pathway remained the dominant ILC-enriched pathways in the MSigDB pathway analysis (Supplementary Fig. S5), further indicating that these results were not a result of lower tumor purity. The gene discussed is CCL27; the disease is neoplasm.